CVD-1301.V01

N/A

Report date: 2025/06/13 11:41:37

Base Information

Drug NameCVD-1301.V01
Drug Alias NamehV-01CVD-1301.V01V 01
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionInterleukin-21 stimulants
TargetsInterleukin-21
Therapy Area/IndicationsSolid tumoursUterine Cervical NeoplasmsPancreatic Neoplasms +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesHangzhou Converd Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesHangzhou Converd Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursUterine Cervical NeoplasmsPancreatic Neoplasms +[4
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A